Probiotics relieve UC symptoms in mice

2 March 2009

A study published in the January 21 issue of the World Journal of Gastroenterology found that four strains of probiotics isolated from  human feces (E.feacalis, L.acidophilus, C.butyricum and B.adolescentis)  relieved symptoms of ulcerative colitis in mice just as well as the  commonly-used drug sulfasalazine.

The team of Chinese scientists observed benefits with probiotics on a  number of measures such as weight loss, colon length, disease activity  index scores, histological scores, proteins and mRNA levels of  interleukin-1 and -4 and myeloperoxidase activity.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight